Impact Factor
2.60
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.86
69 total citations
h5-index
11
h5 depth signal
Cited share
61.9%
26 of 42
Total citations
69
Citation footprint
Metric signal
1.33
External metric anchor
Self-citation
7.2%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
86
United States
40
United Kingdom
28
Canada
25
Italy
22
Citing Fields of Research
Psychiatry
175
Genetics & Genomics
172
Cytogenetics
69
Neurodevelopmental Disorders
51
Neurosciences
30
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,653
Articles tracked across the journal lifetime
Indexed publication set
42
26 cited publications
Last 12 months
27
3.0 publications/month
Open access share
22.2%
6 OA publications in the last year
Leading citing country
China
86 citing publications
Leading citing field
Psychiatry
175 citing publications
Latest tracked publication
9 October 2026
10 recent records available
Coverage & Indexing History
v4n1,spring 1994-
v4n1,spring 1994-
Active Coverage
Research Focus & Classification
Indexed Subjects
Genetics & Genomics
Cytogenetics
Psychiatry
Neurodevelopmental Disorders
Broad Categories
Genetics
Psychiatry
Cytogenetics
Genetics & Genomics
Psychiatry
Noncoding RNA
MeSH Descriptors
Brain
Genetics
Genetics, Behavioral
Mental Disorders
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/ypg.0000000000000424
Open DOI
Causal associations between chronic hepatitis B and major depressive disorder in East Asian populations: a bidirectional two-sample Mendelian randomization study
Background: Epidemiological studies suggest that there is a strong association between chronic hepatitis B (CHB) and major depressive disorder (MDD). However, it remains uncertain whether these associations are causal, as much of the cur...
02
DOI 10.1097/ypg.0000000000000426
Open DOI
UK-based mental health professionals’ perceptions of genetic and environmental risk for psychiatric conditions
Objective: We aimed to uncover UK-based mental health professionals’ knowledge and perceptions of psychiatric genetic risk, comparing those with and without a medical degree to identify training gaps. Methods: Via an online survey, we as...
03
DOI 10.1097/ypg.0000000000000430
Open DOI
The role of PRKRA mutation in antipsychotic-induced extrapyramidal symptoms: a case report and implications for precision psychiatry
Antipsychotic-induced extrapyramidal symptoms (EPS) significantly impact patient adherence and treatment outcomes in schizophrenia. While genetic susceptibility to EPS has been recognized, rare mutations influencing dopamine regulation r...
04
DOI 10.1097/ypg.0000000000000428
Open DOI
Can neurodevelopmental disorders be part of brain-lung-thyroid syndrome? A case report
Mutations in the NKX2-1 gene cause a syndromic disorder affecting the brain, thyroid, and lungs. There are few case reports in the literature discussing the association between NKX2-1 gene mutation and neurodevelopmental disorders. In th...
05
DOI 10.1097/ypg.0000000000000433
Open DOI
CLCN6 mutation in an Indian patient with rapidly progressive dementia
The CLC family of chloride channels and transporters plays crucial roles in endosomal/lysosomal function, with dysfunction contributing to protein aggregation and dementia development. CLCN6 mutations are recognized in early-onset neurod...
06
DOI 10.1097/ypg.0000000000000425
Open DOI
Female-specific associations of glyoxalase 1 polymorphisms with schizophrenia in a Han Chinese case–control study
Background: Emerging evidence suggests that glyoxalase 1 (Glo-1) may contribute to sex-specific phenotypes in schizophrenia. This study aims to investigate the sex-specific effects of Glo-1 polymorphisms on schizophrenia susceptibility. ...
07
DOI 10.1097/ypg.0000000000000427
Open DOI
Disruption of GAD1 protein architecture by a novel missense variant in a consanguineous family with autosomal recessive intellectual disability
Background: Intellectual disability represents a heterogeneous group of neurodevelopmental disorders marked by significant impairments in intellectual functioning and adaptive behavior. Among the various causes, genetic factors play a ma...
08
DOI 10.1097/ypg.0000000000000432
Open DOI
Prenatal diagnosis and genetic counseling of a de novo 10q11.22q11.23 duplication associated with a normal development at 12 months of age
Background: Copy number variants are an important source of genomic variations, ranging from pathogenic to benign. The 10q11.22q11.23 region contains complex low-copy repeats that predispose to recurrent deletions and duplications via no...
09
DOI 10.1097/ypg.0000000000000431
Open DOI
A de novo 1.62 Mb deletion at 2q34 with nonpenetrant neurodevelopmental phenotype at 12 months
Background: Interstitial deletions at chromosome 2q34 are rare and have been associated with a spectrum of neurodevelopmental disorders including intellectual disability, epilepsy, autism spectrum disorder, and behavioral abnormalities. ...
10
DOI 10.1097/ypg.0000000000000421
Open DOI
Contrasting outcomes of 16p11.2 microdeletion and microduplication in prenatal diagnosis: phenotypic variability and genetic counseling strategies
Background: Copy number variations (CNVs) in the 16p11.2 region are associated with neurodevelopmental disorders, but they exhibit incomplete penetrance and variable expressivity. Prenatal diagnosis of these CNVs presents significant cha...
Bibliographical & Catalog Notes
Title from cover.
Vol. 1 consists of one issue.
Also available online.
Vol. 3, no. 1 (SPRING 1993)19940909 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper